Awards
Paul Ehrlich Lectureship Award: Dr. Bruce S. Bochner, MD
The Paul Ehrlich Lectureship Award is the highest honor bestowed by the International Eosinophil Society on an individual who has demonstrated outstanding, prolific, high quality and broad research achievements that have substantially advanced the knowledge regarding the molecular mechanisms governing the eosinophil in health and disease. Dr. Bochner will give the prestigious Paul Ehrlich Lecture on Wednesday, 12 July 2023 at 4:00 pm.
 |
Bruce S. Bochner, MD is Professor Emeritus as of February 1, 2023, after serving as the Samuel M. Feinberg Professor of Medicine in the Division of Allergy and Immunology at the Northwestern University Feinberg School of Medicine. After postdoctoral training in allergy and immunology at Johns Hopkins in the Division of Allergy and Clinical Immunology, he joined the faculty in 1988, was promoted to professor in 1999 and subsequently served as Division Director from 2003 to 2013 before accepting the professorship at Northwestern. His primary interests centered on the function and regulation of eosinophils and mast cells. He is an author on over 300 manuscripts, and has served in leadership roles for the International Eosinophil Society. |
Eosinophilic Disease Translational Research Award: Dr. Amy D. Klion, MD
The Eosinophilic Disease Translational Research Award is a new award created to recognize a scientist whose translational research has helped lead to substantial improvement in the understanding, diagnosis and care of patients afflicted by eosinophilic disease. Patient-oriented translational research is a critical component towards improving outcomes in the era of personalized medicine, both for individual patients and for the community-at-large. Dr. Klion will receive this award and recognition during the Networking and Awards Dinner on the evening of Friday, 14 July.
 |
Amy D. Klion, MD is a Senior Investigator, head of the Human Eosinophil Section and Deputy Chief of the Laboratory of Parasitic Diseases at the NIH. Her research program includes basic and translational research related to the role of the eosinophil and eosinophil activation in disease pathogenesis. The ultimate goal of her laboratory is to develop novel diagnostic tools and treatment approaches for hypereosinophilic syndromes and other conditions associated with marked eosinophilia, including helminth infection. Dr. Klion is a Fellow of the American Society of Tropical Medicine and Hygiene and a recipient of the Society’s Bailey K. Ashford Medal. She has served on the editorial boards of Blood and the Journal of Allergy and Clinical Immunology and numerous advisory committees and expert panels related to her work on eosinophilic disorders and neglected tropical diseases. She is the author of more than 200 scholarly articles, reviews, and textbook chapters. |
Gerald J. Gleich Awardees
The International Eosinophil Society (IES) is pleased to announce the winners of the Gerald J. Gleich Award, which is given biennially to the most intriguing, high impact publication in eosinophil biology published in the prior two years. For the first time, two awardees have been selected for their significant scientific contributions: Dr. Emilie J. Cosway and Dr. Sharon Grisaru-Tal.The awardees will present their work on Friday, 14 July during the upcoming 12th Biennial Symposium of the International Eosinophil Society.
This prestigious award is named in honor of and funded by Dr. Gerald J. Gleich, whose career has been devoted to the exploration of the eosinophilic leukocyte and to the elucidation of its role in health and disease.
Dr. Emilie J. Cosway, PhD
Publication: Eosinophils Are An Essential Element Of A Type 2 Immune Axis That Controls Thymus Regeneration
 |
Dr. Emilie J. Cosway studied Medical Science as an undergraduate at the University of Birmingham before obtaining a PhD in Immunology and Immunotherapy at the University of Birmingham/University of Glasgow, funded by Versus Arthritis (Rheumatoid Arthritis Centre of Excellence). Her PhD focused on investigating the role of accessory cells in the thymus microenvironment for central tolerance and thymus regeneration. She is currently a postdoctoral researcher exploring the mechanisms regulating thymus regeneration. |
Dr. Sharon Grisaru-Tal, MD, PhD
Publication: Metastasis-Entrained Eosinophils Enhance Lymphocyte-Mediated Antitumor Immunity
 |
|
IES Service Awardees
The IES Service Award is given in recognition of dedicated service to the International Eosinophil Society and to the larger community of eosinophil scientists. The award recognizes an individual who exhibits the highest standard of excellence, dedication, and accomplishment over a sustained period of time. These contributions may be in a wide variety of areas, including but not limited to increasing public awareness of the mission of the Society and the promotion of research, education and training in the field of eosinophil biology and eosinophilic disorders.
Because there has been no awardee since the 2019 Symposium, the IES is pleased to recognize two outstanding individuals with this award in 2023: Dr. Allison Fryer and Dr. Florence Roufosse.
Dr. Allison Fryer, PhD
|
|
Dr. Florence Roufosse, MD, PhD
 |
Dr. Florence Roufosse is Professor of Medicine, Internist and Clinical Immunologist at CUB- Hôpital Erasme, Brussels, and is President of the International Eosinophil Society. She is in charge of a specialized consultation dedicated to diagnosing and treating eosinophil-related conditions, that is integrated in the European Reference Network: EuroBloodNet. She also manages patients with systemic auto-immune and auto-inflammatory conditions. Besides these clinical activities, Dr. Roufosse leads translational research projects to improve understanding and treatment of lymphocytic variant hypereosinophilic syndrome (HES), and participates in international research efforts to better delineate disease course and treatment responses in patients with HES HES. She is involved in the design and conduct of international clinical trials evaluating efficacy of novel treatment options for HES and eosinophilic granulomatosis with polyangiitis (EGPA), as well as sub-studies that aim to identify biomarkers and/or disease variants predicting treatment responses. |
